AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
PLASMA-LEVELS OF D-DIMER AND CIRCULATING ENDOTHELIAL ADHESION MOLECULES IN VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SUDHOFF T HEINS M SOHNGEN D LENZ V WEHMEIER A AUL C MECKENSTOCK G SCHNEIDER W REINAUER H HEYLL A
Citation: T. Sudhoff et al., PLASMA-LEVELS OF D-DIMER AND CIRCULATING ENDOTHELIAL ADHESION MOLECULES IN VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, European journal of haematology, 60(2), 1998, pp. 106-111
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL)
Authors: KOBBE G BAUSER U RIETH C HUNERLITURKOGLU A SOHNGEN D AIVADO M AUL C HEYLL A
Citation: G. Kobbe et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL), American journal of hematology, 58(4), 1998, pp. 330-333
T-CELL ACTIVATION AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - THE ROLE OF CONDITIONING, CD34+ SELECTION AND SERUM CYTOKINES
Authors: SCHEID C FUCHS M NOCKENBERG C HINRICHS R DRAUBE A WINTER S JUNGINGER H CHEMNITZ J SOHNGEN D DIEHL V SCHULZ A
Citation: C. Scheid et al., T-CELL ACTIVATION AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - THE ROLE OF CONDITIONING, CD34+ SELECTION AND SERUM CYTOKINES, Bone marrow transplantation, 21, 1998, pp. 54-54
HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA
Authors: HUNERLITURKOGLU A KOBBE G SOHNGEN D BAUSER U SCHNEIDER P THIELE KP MINNING H SUDHOFF T MECKENSTOCK G STRUPP C NIEDERSTEHOLLENBERG A AUL C HEYLL A
Citation: A. Hunerliturkoglu et al., HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 589-589
HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA
Authors: SCHNEIDER P SOHNGEN D KOBBE G BAUSER U HUNERLITURKOGLU A HEYLL A AUL C
Citation: P. Schneider et al., HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA, Bone marrow transplantation, 21, 1998, pp. 707-707
ANAPHYLACTIC REACTION TO LIPOSOMAL AMPHOTERICIN (AMBISOME)
Authors: SCHNEIDER P KLEIN RM DIETZE L SOHNGEN D LESCHKE M HEYLL A
Citation: P. Schneider et al., ANAPHYLACTIC REACTION TO LIPOSOMAL AMPHOTERICIN (AMBISOME), British Journal of Haematology, 102(4), 1998, pp. 1108-1109
ACUTE ACALCULOUS CHOLECYSTITIS COMPLICATING ORAL RECONTAMINATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KOBBE G HEYLL A ZODLER T SOHNGEN D AUL C THIELE KP GERMING U SCHNEIDER W
Citation: G. Kobbe et al., ACUTE ACALCULOUS CHOLECYSTITIS COMPLICATING ORAL RECONTAMINATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Oncology Reports, 4(4), 1997, pp. 823-824
CEREBRAL MICROEMBOLI IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Authors: SPECKER C RADEMACHER J SOHNGEN D SITZER M JANDA I SIEBLER M STEINMETZ H SCHNEIDER M
Citation: C. Specker et al., CEREBRAL MICROEMBOLI IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, Lupus, 6(8), 1997, pp. 638-644
ACQUIRED FACTOR-VIII INHIBITORS IN NONHEMOPHILIC PATIENTS
Authors: SOHNGEN D SPECKER C BACH D KUNTZ BME BURK M AUL C KOBBE G HEYLL A HOLLMIG KA SCHNEIDER W
Citation: D. Sohngen et al., ACQUIRED FACTOR-VIII INHIBITORS IN NONHEMOPHILIC PATIENTS, Annals of hematology, 74(2), 1997, pp. 89-93
IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS
Authors: HEYLL A SOHNGEN D KOBBE G SCHNEIDER P BAUSER U THIELE KP WEHMEIER A SUDHOFF T QUENZEL EM RIETH C WERNET P FISCHER J FRICK M AUL C
Citation: A. Heyll et al., IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS, Leukemia, 11, 1997, pp. 32-34
DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR
Authors: SOHNGEN D BAUSER U BOOGEN C AUL C FRIELING T GERMING U SCHNEIDER P KOBBE G HEYLL A
Citation: D. Sohngen et al., DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1299-1300
DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION INPATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KORHOLZ D KUNST D HEMPEL L SOHNGEN D HEYLL A BONIG H GOBEL U ZINTL F BURDACH S
Citation: D. Korholz et al., DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION INPATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(7), 1997, pp. 691-695
COMPRESSION THERAPY FOR VENOUS THROMBOSIS OF THE LOWER-EXTREMITIES
Authors: SOHNGEN D SCHNEIDER W
Citation: D. Sohngen et W. Schneider, COMPRESSION THERAPY FOR VENOUS THROMBOSIS OF THE LOWER-EXTREMITIES, Der Internist, 38(12), 1997, pp. 1231-1233
PROGNOSTIC-SIGNIFICANCE OF SERUM THYMIDIN E KINASE IN THE MYELODYSPLASTIC SYNDROME
Authors: AUL C GERMING U GATTERMANN N SOHNGEN D HEYLL A
Citation: C. Aul et al., PROGNOSTIC-SIGNIFICANCE OF SERUM THYMIDIN E KINASE IN THE MYELODYSPLASTIC SYNDROME, Deutsche Medizinische Wochenschrift, 121(37), 1996, pp. 1113-1118
SEVERE MUSCULOSKELETAL PAIN AFTER CYCLOSPORINE-A TREATMENT IN A PATIENT UNDERGOING ALLOGENEIC BMT
Authors: GERMING U SOHNGEN D HEYLL A KOBBE G AUL C SCHNEIDER W
Citation: U. Germing et al., SEVERE MUSCULOSKELETAL PAIN AFTER CYCLOSPORINE-A TREATMENT IN A PATIENT UNDERGOING ALLOGENEIC BMT, Oncology Reports, 3(4), 1996, pp. 775-776
G-CSF PRIMING AND PBPC APHERESIS IN UNRELATED DONORS FOR ALLOGRAFTING- 14 MONTHS EXPERIENCE
Authors: FISCHER J KOBBE G SOHNGEN D HEYLL A KOGLER G WERNET P
Citation: J. Fischer et al., G-CSF PRIMING AND PBPC APHERESIS IN UNRELATED DONORS FOR ALLOGRAFTING- 14 MONTHS EXPERIENCE, Experimental hematology, 24(9), 1996, pp. 673-673
HUMORAL IMMUNODEFICIENCY IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION
Authors: KORHOLZ D KUNST D HEMPEL L SOHNGEN D HEYLL A MAUZKORHOLZ C ZINTL F BURDACH S
Citation: D. Korholz et al., HUMORAL IMMUNODEFICIENCY IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1123-1130
A DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE IS CAUSING A HUMORAL IMMUNODEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KORHOLZ D HEMPEL L KUNST D SOHNGEN D HEYLL A ZINTL F BURDACH S
Citation: D. Korholz et al., A DECREASED INTERLEUKIN-10 AND INCREASED INTERFERON-GAMMA PRODUCTION IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE IS CAUSING A HUMORAL IMMUNODEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2563-2563
ACQUIRED FACTOR-VIII-C INHIBITOR ANTIBODI ES IN NONHEMOPHILIC PATIENTS
Authors: SOHNGEN D KUNTZ BME HEINS M SPECKER C BACH D BURK M AUL C SCHNEIDER W
Citation: D. Sohngen et al., ACQUIRED FACTOR-VIII-C INHIBITOR ANTIBODI ES IN NONHEMOPHILIC PATIENTS, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 56-59
HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - SUCCESSFUL USE OF ORGARAN (ORG-10172) IN INTENSIVE-CARE PATIENTS
Authors: BURKHARDMEIER U SOHNGEN D SCHULTHEISS HP GREINACHER A SCHWARTZKOPFF B VOGT M HEYLL A SCHNEIDER W
Citation: U. Burkhardmeier et al., HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - SUCCESSFUL USE OF ORGARAN (ORG-10172) IN INTENSIVE-CARE PATIENTS, Intensive care medicine, 21(6), 1995, pp. 542-543
ANTIPHOSPHOLIPID ANTIBODIES AND RELATED CLINICAL-FEATURES
Authors: SOHNGEN D SPECKER C RADEMACHER J DITTMANN U SCHUPPE HC HEINS M STEINMETZ H SITZER M WEHMEIER A SCHNEIDER W
Citation: D. Sohngen et al., ANTIPHOSPHOLIPID ANTIBODIES AND RELATED CLINICAL-FEATURES, Thrombosis and haemostasis, 73(6), 1995, pp. 1278-1278
ANTIPHOSPHOLIPID ANTIBODIES-RELATED CLINICAL-FEATURES IN A PATIENT WITH THYMITIS
Authors: SOHNGEN D TSAMALOUKAS AG FREHEN D SPECKER C HEINS M RADEMACHER I SCHNEIDER W
Citation: D. Sohngen et al., ANTIPHOSPHOLIPID ANTIBODIES-RELATED CLINICAL-FEATURES IN A PATIENT WITH THYMITIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1278-1278
MOLECULAR HISTOCOMPATIBILITY MATCHING-STRATEGY FOR UNRELATED BONE-MARROW TRANSPLANTATION
Authors: ENCZMANN J KNIPPER A UHRBERG M SCHUCH B HEYLL A SOHNGEN D SCHNEIDER W BURDACH S GOBEL U WERNET P
Citation: J. Enczmann et al., MOLECULAR HISTOCOMPATIBILITY MATCHING-STRATEGY FOR UNRELATED BONE-MARROW TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 744-744
DEPENDENCE OF PERIPHERAL-BLOOD STEM-CELL (PBSC) YIELD COLLECTED IN PATIENTS WITH MALIGNANT-LYMPHOMA AND MULTIPLE-MYELOMA ON THE EXTENT OF PREVIOUS RADIOCHEMOTHERAPY AND THE DOSE OF G-CSF
Authors: HEYLL A KOBBE G SOHNGEN D MECKENSTOCK G AUL C ILLES A KOGLER G WERNET P
Citation: A. Heyll et al., DEPENDENCE OF PERIPHERAL-BLOOD STEM-CELL (PBSC) YIELD COLLECTED IN PATIENTS WITH MALIGNANT-LYMPHOMA AND MULTIPLE-MYELOMA ON THE EXTENT OF PREVIOUS RADIOCHEMOTHERAPY AND THE DOSE OF G-CSF, Experimental hematology, 23(8), 1995, pp. 758-758
THE USE OF PHOTOCHEMOTHERAPY IN THE MANAGEMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) - 2 CASE-REPORTS
Authors: STEGE H NURNBERGER W BURDACH S HEYLL A SOHNGEN D LEHMANN P RUZICKA T KRUTMANN J
Citation: H. Stege et al., THE USE OF PHOTOCHEMOTHERAPY IN THE MANAGEMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) - 2 CASE-REPORTS, Experimental hematology, 23(8), 1995, pp. 859-859
Risultati: 1-25 | 26-39